{"id":1539,"date":"2017-08-29T12:57:57","date_gmt":"2017-08-29T10:57:57","guid":{"rendered":"https:\/\/www.europlasma.com\/investisseurs-et-actionnaires\/information-reglementee\/"},"modified":"2022-02-09T15:25:02","modified_gmt":"2022-02-09T14:25:02","slug":"information-reglementee","status":"publish","type":"page","link":"https:\/\/www.europlasma.com\/en\/investisseurs-et-actionnaires\/information-reglementee\/","title":{"rendered":"Regulated information"},"content":{"rendered":"

[vc_row row_height_percent=”0″ back_color=”color-xsdn” overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ css=”.vc_custom_1504194476504{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 70px !important;padding-bottom: 140px !important;}”][vc_column width=”1\/1″]

<\/div>

REGULATED INFORMATION<\/h2><\/div><\/div>[vc_tabs el_class=”info-reglementee”][vc_tab title=”Financial statements” tab_id=”1504195185818-2-6″][vc_empty_space empty_h=”3″]
<\/div>
FINANCIAL STATEMENTS OF THE GROUP & PARENT COMPANY (IN FRENCH)<\/div><\/div>[uncode_index el_id=”index-319672″ loop=”size:All|order_by:date|order:DESC|post_type:information|tax_query:34″ filtering=”yes” filtering_position=”center” gutter_size=”3″ information_items=”text|full” screen_lg=”1000″ screen_md=”600″ screen_sm=”480″ single_width=”12″ single_overlay_opacity=”50″ single_h_align=”center” single_padding=”2″ single_title_transform=”uppercase” single_title_family=”font-364912″ el_class=”publication-comptes”][\/vc_tab][vc_tab title=”Information on capital” tab_id=”1504510114391-4-0″][vc_empty_space empty_h=”3″]
<\/div>
VOTING RIGHTS AND SHARES<\/div><\/div>
<\/div>
Information concerning the number of shares and voting rights<\/span> (Article L. 233-8 II of the Commercial Code, art. 55 of the law)<\/span><\/span><\/div><\/div>[uncode_index el_id=”index-319672″ loop=”size:All|order_by:date|order:DESC|post_type:information|tax_query:52″ filtering=”yes” filtering_position=”center” gutter_size=”3″ information_items=”text|full” screen_lg=”1000″ screen_md=”600″ screen_sm=”480″ single_width=”12″ single_overlay_opacity=”50″ single_h_align=”center” single_padding=”2″ single_title_transform=”uppercase” single_title_family=”font-364912″ el_class=”info-capital”][\/vc_tab][vc_tab title=”Liquidity report” tab_id=”1504106490-1-13″][vc_empty_space empty_h=”3″]
<\/div>
MONTHLY DECLARATION OF TRADING IN OWN SHARES UNDER THE LIQUIDITY CONTRACT<\/div><\/div>
<\/div>
Nature of securities : share
\nShare capital owned directly at the date of publication of the program : 0\/0<\/p>\n

The Company terminated the liquidity contract on February 5, 2019<\/div><\/div>[uncode_index el_id=”index-319672″ loop=”size:All|order_by:date|order:DESC|post_type:information|tax_query:16″ filtering=”yes” filtering_position=”center” gutter_size=”3″ information_items=”date,title,text|full” screen_lg=”1000″ screen_md=”600″ screen_sm=”480″ single_back_color=”color-xsdn” single_overlay_opacity=”50″ single_h_align=”center” single_padding=”2″ single_title_transform=”uppercase” single_title_family=”font-364912″ single_shadow=”yes” shadow_weight=”sm” el_class=”liquidity-contract”][\/vc_tab][vc_tab title=”Financial press release” tab_id=”1504267458800-3-7″][vc_empty_space empty_h=”3″]

<\/div>
FINANCIAL PRESS RELEASE<\/div><\/div>[uncode_index el_id=”index-319672″ isotope_mode=”fitRows” loop=”size:All|order_by:date|order:DESC|post_type:information|tax_query:43″ filtering=”yes” filtering_position=”center” gutter_size=”3″ information_items=”title,text|full” screen_lg=”1000″ screen_md=”600″ screen_sm=”480″ single_back_color=”color-xsdn” single_overlay_opacity=”50″ single_h_align=”center” single_padding=”2″ single_shadow=”yes” shadow_weight=”sm” shadow_darker=”yes” el_class=”ref-docs com-finances”][\/vc_tab][\/vc_tabs][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row row_height_percent=”0″ back_color=”color-xsdn” overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ css=”.vc_custom_1504194476504{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 70px !important;padding-bottom: 140px !important;}”][vc_column width=”1\/1″][vc_tabs el_class=”info-reglementee”][vc_tab title=”Financial […]<\/p>\n","protected":false},"author":1,"featured_media":362,"parent":1536,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-invest.php","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/1539"}],"collection":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/comments?post=1539"}],"version-history":[{"count":8,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/1539\/revisions"}],"predecessor-version":[{"id":6497,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/1539\/revisions\/6497"}],"up":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/pages\/1536"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/media\/362"}],"wp:attachment":[{"href":"https:\/\/www.europlasma.com\/en\/wp-json\/wp\/v2\/media?parent=1539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}